Suscribirse

Quality of evidence supporting Surviving Sepsis Campaign Recommendations - 02/08/20

Doi : 10.1016/j.accpm.2020.06.015 
Jordi Rello a, b, c, 1, Sofia Tejada a, b, , 1 , Elena Xu d, Candela Solé-Lleonart e, Laura Campogiani f, Despoina Koulenti d, g, João Ferreira-Coimbra h, Jeff Lipman c, d
a Clinical Research/Epidemiology in Pneumonia & Sepsis (CRIPS), Vall d’Hebron Institut of Research (VHIR), Barcelona, Spain 
b Centro de Investigacion Biomedica En Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain 
c Scientifical Research, CHU Nîmes, University Montpellier-Nîmes, Nîmes, France 
d UQ Centre for Clinical Research, Faculty of Medicine, University of Queensland, Brisbane, Australia 
e Intensive Care Unit. Hospital Universitari de Vic, Barcelona, Spain 
f Clinical Infectious Diseases, Department of System Medicine, Tor Vergata University, Rome, Italy 
g Department of Critical Care II, Attikon University Hospital, Athens, Greece 
h Internal Medicine Department, Centro Hospitalar Universitário do Porto, Porto, Portugal 

Corresponding author. CIBERES - Vall d’Hebron Institut de Recerca, Clinical Research/epidemiology In Pneumonia & Sepsis (CRIPS), Ps. Vall d’Hebron 119 - AMI 14th floor, 08035 Barcelona, Spain.CIBERES - Vall d’Hebron Institut de Recerca, Clinical Research/epidemiology In Pneumonia & Sepsis (CRIPS)Ps. Vall d’Hebron 119 - AMI 14th floorBarcelona08035Spain
En prensa. Pruebas corregidas por el autor. Disponible en línea desde el Sunday 02 August 2020
This article has been published in an issue click here to access

Abstract

Introduction

The Surviving Sepsis Campaign (SSC) guidelines, released in 2017, are a combination of expert opinion and evidence-based medicine, adopted by many institutions as a standard of practice. The aim was to analyse the quality of evidence supporting recommendations on the management of sepsis.

Methods

The strength and quality of evidence (high, moderate, low-very low and best practice statements) of each recommendation were extracted. Randomised controlled trials were required to qualify as high-quality evidence.

Results

A total of 96 recommendations were formulated, and 87 were included. Among thirty-one (43%) strong recommendations, only 15.2% were supported by high-quality evidence. Overall, thirty-seven (42.5%) recommendations were based on low-quality evidence, followed by 28 (32.2%) based on moderate-quality, 15 (17.2%) were best practice statements and only seven (8.0%) were supported by high-quality evidence. Randomised controlled trials supported 21.4%, 9.5% and 8.6% recommendations on mechanical ventilation, resuscitation, and management/adjuvant therapy, respectively. In contrast, none high-quality evidence recommendation supported antimicrobial/source control (82.4% were low-very low evidence or best practice statements), and nutrition.

Conclusions

In the SSC guidelines most recommendations were informed by indirect evidence and non-systematic observations. While awaiting trials results, Delphi-like approaches or multi-criteria decision analyses should guide recommendations.

El texto completo de este artículo está disponible en PDF.

Keywords : Antimicrobial administration, Haemodynamic resuscitation, Mechanical ventilation, Clinical practice guidelines, Septic shock

Abbreviations : ARDS, BPS, CPG, GRADE, LOE, MCDA, PRISMA, RCT, SCC, WHO


Esquema


© 2020  Société française d'anesthésie et de réanimation (Sfar). Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.